Obsidian Therapeutics, Inc. Common Stock Net Asset Momentum
Obsidian Therapeutics, Inc. Common Stock net asset momentum. Obsidian Therapeutics, Inc. Common Stock (OBX) recorded a net asset momentum of -52.5% as of December 2025, with net assets of $-266.04 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See OBX book value for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Obsidian Therapeutics, Inc. Common Stock (2024–2025)
Net asset momentum of Obsidian Therapeutics, Inc. Common Stock from 2024 to 2025. This chart tracks Obsidian Therapeutics, Inc. Common Stock's year-over-year net asset growth across 2 annual reporting periods from 2024 to 2025. The most recent momentum reading is -52.5%, with net assets of $-266.04 Million USD as of December 2025.
Obsidian Therapeutics, Inc. Common Stock Net Asset Momentum by Year (2024–2025)
Obsidian Therapeutics, Inc. Common Stock net asset momentum by year from 2024 to 2025. The table below shows the complete annual net asset history for Obsidian Therapeutics, Inc. Common Stock from 2024 to 2025, covering 2 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see Obsidian Therapeutics, Inc. Common Stock (OBX) total market value.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $-266.04 Million | $88.58 Million | $354.62 Million | ▼ -52.5% |
| 2024 | $-174.43 Million | $183.71 Million | $358.14 Million | — |